The Patent Finder

Terms ending in 2035

Respivert Limited

Every in-force patent on Respivert Limited's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,447,076Inhibitor of P38 Map Kinase
In force
 · High confidence
Respivert LimitedIn forceHigh confidence
US 9,624,196Inhibitor of P38 Map Kinase
In force
 · High confidence
Respivert LimitedIn forceHigh confidence
US 9,884,845Pyrazolyl Ureas as Kinase Inhibitors
In force
 · High confidence
Respivert LimitedIn forceHigh confidence
US 10,045,980INHIBITOR OF p38 MAP KINASE
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
US 10,294,216Pyrazolyl Ureas as Kinase Inhibitors
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
US 10,815,217INHIBITOR OF p38 MAP KINASE
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
US 11,142,515Pyrazolyl-Ureas as Kinase Inhibitors
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
US 11,634,406INHIBITOR OF p38 MAP KINASE
In force
 · Medium confidence
Respivert LimitedIn forceMedium confidence
US 10,125,100Kinase Inhibitors
Grace period ended Nov 13, 2026 · lapse expected
 · Low confidence
Oxular Acquisitions LimitedGrace period ended Nov 13, 2026
lapse expected
Low confidence
US 10,392,346Kinase Inhibitors
In force
 · High confidence
Oxular Acquisitions LimitedIn forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Respivert Limited.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited